Parade: New Research and Interventions Give Us Good News About Alzheimer’s Disease in 2022

Parade magazine covers the new research and interventions that are bringing what it calls good news to patients and families dealing with Alzheimer’s disease. It included in the article details about blood tests that help healthcare providers diagnose Alzheimer’s and highlighted the PrecivityAD™ test as the first one that is determining the presence of amyloid plaques in the brain, a hallmark of the disease.

Previous
Previous

USA Today: A new era of diagnosis for Alzheimer's disease': Scientists study blood tests for dementia

Next
Next

HEC-TV: St. Louis-Based C₂N Diagnostics has a Blood Test for Alzheimer’s Disease That’s Now in the Market